- Publications
 - Search
 - Statistics
 
Cell Activity After Cell Growth Inhibition by the Irf-1 System
                        AuthID
P-001-5BF
        P-001-5BF
                        4                    
                    Author(s)
                
                        4                    
                    Editor(s)
                
                Bernard, A; Griffiths, B; Noe, W; Wurm, F            
        Document Type
            
            Proceedings Paper        
    Year published
                
                1999            
        Published
            in ANIMAL CELL TECHNOLOGY: PRODUCTS FROM CELLS, CELLS AS PRODUCTS
                Pages: 139-141 (3)
                                Conference
                16Th Meeting of the European-Society-For-Animal-Cell-Technology (Esact), Date: APR 25-29, 1999, Location: LUGANO, SWITZERLAND, Sponsors: Akzo Nobel Pharma, Amersham Pharmacia Biotech, Ares Serono SA, B Braun Biotech Int GmbH, Bayer Corp, Bioengn AG, BioWhittaker Inc, Boehringer Ingelheim Pharm KG, BioInvent Prod AB, Canberra Packard SA, Cansera Int Inc, Cantone Ticino, Crossair Swissair, E Merck, Genentech Inc, Genet Inst, Genzyme Transgen Corp, Hoffmann La Roche AG, Hyclone Europe SA, Immuno AG, Div Baxter Inc, Immunex Corp, Inst Rech Pierre Fabre, Intervet Int BV, Inveresk Res Int Ltd, JRH Biosci, Life Technologies Ltd, Lonza Biol Plc, MA Bioserv, Merck Res Labs, MicroSafe BV, Novartis Pharma AG, Novo Nordisk AS, Nunc AS, Pall Europe Ltd, Pasteur Merieux Connaught, PCS Process Control Syst AG, Pharmacia & Upjohn AB, Q One Biotech Ltd, Sanofi Rech, Scharfe Syst GmbH, Schering AG, Swiss Red Cross, ZLB, SmithKline Beecham Biol, Union Bank Switzerland
            Indexing
            Publication Identifiers
        Wos: WOS:000085945800031
                                        Export Publication Metadata
        Publication Export Settings
Marked List
        Info
            
            At this moment we don't have any links to full text documens.